rs751010317
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_030787.4(CFHR5):c.993C>A(p.Cys331*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000584 in 1,558,944 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_030787.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFHR5 | NM_030787.4 | c.993C>A | p.Cys331* | stop_gained | 7/10 | ENST00000256785.5 | NP_110414.1 | |
CFHR5 | XM_011510020.3 | c.1002C>A | p.Cys334* | stop_gained | 7/10 | XP_011508322.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFHR5 | ENST00000256785.5 | c.993C>A | p.Cys331* | stop_gained | 7/10 | 1 | NM_030787.4 | ENSP00000256785.4 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151916Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000121 AC: 22AN: 182146Hom.: 0 AF XY: 0.000154 AC XY: 15AN XY: 97488
GnomAD4 exome AF: 0.0000618 AC: 87AN: 1407028Hom.: 0 Cov.: 28 AF XY: 0.0000919 AC XY: 64AN XY: 696444
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151916Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74198
ClinVar
Submissions by phenotype
CFHR5 deficiency Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | Dec 18, 2017 | - - |
CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Dec 05, 2018 | The CFHR5 c.993C>A (p.Cys331Ter) variant is a stop-gained variant predicted to result in premature termination of the protein. The variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018) and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score for this variant, it could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change. No publications were found based on this search. Due to the potential impact of stop-gained variants and the lack of clarifying evidence, this variant is classified as a variant of unknown significance but suspicious for pathogenicity for this disease. - |
C3 glomerulonephritis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jan 31, 2024 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at